US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist

3.640
+0.100+2.82%

Trading Apr 29 09:33 ET

80.87MMarket Cap-1905P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

11.96%-27.36M

4.69%-6.18M

28.49%-6.49M

24.03%-6.39M

-16.83%-8.3M

-19.71%-31.07M

18.86%-6.48M

23.05%-9.07M

-6,725.20%-8.41M

-12.63%-7.11M

Net income from continuing operations

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

-10.32%-8.95M

-29.90%-9.17M

-58.56%-8.49M

Depreciation and amortization

-40.28%381K

-60.83%85K

-56.22%88K

-25.89%83K

15.74%125K

70.59%638K

112.75%217K

87.85%201K

28.74%112K

38.46%108K

Other non cash items

20.00%1.88M

5.57%474K

69.57%468K

-2.77%457K

29.33%485K

6.15%1.57M

20.05%449K

-49.36%276K

11.64%470K

169.78%375K

Change In working capital

-408.41%-2.68M

-122.42%-343K

21.15%-820K

207.18%209K

-400.70%-1.72M

241.60%868K

259.38%1.53M

77.52%-1.04M

-103.11%-195K

144.35%573K

-Change in prepaid assets

-78.91%193K

-96.72%41K

72.16%-218K

47.96%398K

-115.73%-28K

611.17%915K

439.02%1.25M

1.76%-783K

-79.88%269K

150.86%178K

-Change in payables and accrued expense

-185.21%-1.24M

-99.12%5K

-171.05%-81K

14.29%32K

-261.05%-1.2M

139.93%1.45M

328.00%570K

103.27%114K

-99.44%28K

205.70%742K

-Change in other current liabilities

-8.66%-1.63M

-33.68%-389K

-40.43%-521K

55.08%-221K

-44.09%-500K

-44.33%-1.5M

14.66%-291K

-6.30%-371K

-347.27%-492K

-44.58%-347K

Cash from discontinued investing activities

Operating cash flow

11.96%-27.36M

4.69%-6.18M

28.49%-6.49M

24.03%-6.39M

-16.83%-8.3M

-19.71%-31.07M

18.86%-6.48M

23.05%-9.07M

-6,725.20%-8.41M

-12.63%-7.11M

Investing cash flow

Cash flow from continuing investing activities

69.75%-170K

98.03%-7K

-23.16%-117K

-1,433.33%-46K

-479.38%-562K

-1,218.52%-356K

-871.43%-108K

-35.71%-95K

78.57%-3K

Net PPE purchase and sale

69.75%-170K

98.03%-7K

--0

-23.16%-117K

-1,433.33%-46K

-316.30%-562K

-1,218.52%-356K

-350.00%-108K

-35.71%-95K

78.57%-3K

Cash from discontinued investing activities

Investing cash flow

69.75%-170K

98.03%-7K

--0

-23.16%-117K

-1,433.33%-46K

-479.38%-562K

-1,218.52%-356K

-871.43%-108K

-35.71%-95K

78.57%-3K

Financing cash flow

Cash flow from continuing financing activities

212.22%35.6M

826.81%34.35M

-94.00%21K

-91.74%1.19M

-96.86%44K

-80.69%11.4M

-52,411.11%-4.73M

-88.95%350K

-64.90%14.38M

-90.61%1.4M

Net issuance payments of debt

--0

----

-131.59%-4.74M

----

Net common stock issuance

301.78%35.6M

286,141.67%34.35M

-94.02%21K

-83.26%1.19M

-96.86%44K

-73.49%8.86M

124.49%12K

-89.87%351K

-76.36%7.1M

--1.4M

Proceeds from stock option exercised by employees

--0

----

6,641.67%7.28M

----

Cash from discontinued financing activities

Financing cash flow

212.22%35.6M

826.81%34.35M

-94.00%21K

-91.74%1.19M

-96.86%44K

-80.69%11.4M

-52,411.11%-4.73M

-88.95%350K

-64.90%14.38M

-90.61%1.4M

Net cash flow

Beginning cash position

-39.03%31.6M

-73.34%11.51M

-65.43%17.97M

-49.50%23.29M

-39.03%31.6M

175.39%51.83M

-27.78%43.16M

-24.06%51.99M

68.08%46.12M

175.39%51.83M

Current changes in cash

139.91%8.08M

343.64%28.17M

26.77%-6.47M

-190.69%-5.32M

-45.52%-8.31M

-161.29%-20.23M

-44.13%-11.56M

-2.58%-8.83M

-85.70%5.87M

-166.21%-5.71M

End cash Position

25.56%39.67M

-73.34%11.51M

-65.43%17.97M

-49.50%23.29M

-39.03%31.6M

-27.78%43.16M

-24.06%51.99M

68.08%46.12M

Free cash flow

12.98%-27.53M

9.55%-6.18M

29.34%-6.49M

23.50%-6.51M

-17.43%-8.35M

-21.24%-31.63M

14.69%-6.84M

22.29%-9.18M

-15,028.07%-8.51M

-12.43%-7.11M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	11.96%-27.36M	4.69%-6.18M	28.49%-6.49M	24.03%-6.39M	-16.83%-8.3M	-19.71%-31.07M	18.86%-6.48M	23.05%-9.07M	-6,725.20%-8.41M	-12.63%-7.11M
Net income from continuing operations	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M	-10.32%-8.95M	-29.90%-9.17M	-58.56%-8.49M
Depreciation and amortization	-40.28%381K	-60.83%85K	-56.22%88K	-25.89%83K	15.74%125K	70.59%638K	112.75%217K	87.85%201K	28.74%112K	38.46%108K
Other non cash items	20.00%1.88M	5.57%474K	69.57%468K	-2.77%457K	29.33%485K	6.15%1.57M	20.05%449K	-49.36%276K	11.64%470K	169.78%375K
Change In working capital	-408.41%-2.68M	-122.42%-343K	21.15%-820K	207.18%209K	-400.70%-1.72M	241.60%868K	259.38%1.53M	77.52%-1.04M	-103.11%-195K	144.35%573K
-Change in prepaid assets	-78.91%193K	-96.72%41K	72.16%-218K	47.96%398K	-115.73%-28K	611.17%915K	439.02%1.25M	1.76%-783K	-79.88%269K	150.86%178K
-Change in payables and accrued expense	-185.21%-1.24M	-99.12%5K	-171.05%-81K	14.29%32K	-261.05%-1.2M	139.93%1.45M	328.00%570K	103.27%114K	-99.44%28K	205.70%742K
-Change in other current liabilities	-8.66%-1.63M	-33.68%-389K	-40.43%-521K	55.08%-221K	-44.09%-500K	-44.33%-1.5M	14.66%-291K	-6.30%-371K	-347.27%-492K	-44.58%-347K
Cash from discontinued investing activities
Operating cash flow	11.96%-27.36M	4.69%-6.18M	28.49%-6.49M	24.03%-6.39M	-16.83%-8.3M	-19.71%-31.07M	18.86%-6.48M	23.05%-9.07M	-6,725.20%-8.41M	-12.63%-7.11M
Investing cash flow
Cash flow from continuing investing activities	69.75%-170K	98.03%-7K	0	-23.16%-117K	-1,433.33%-46K	-479.38%-562K	-1,218.52%-356K	-871.43%-108K	-35.71%-95K	78.57%-3K
Net PPE purchase and sale	69.75%-170K	98.03%-7K	--0	-23.16%-117K	-1,433.33%-46K	-316.30%-562K	-1,218.52%-356K	-350.00%-108K	-35.71%-95K	78.57%-3K
Cash from discontinued investing activities
Investing cash flow	69.75%-170K	98.03%-7K	--0	-23.16%-117K	-1,433.33%-46K	-479.38%-562K	-1,218.52%-356K	-871.43%-108K	-35.71%-95K	78.57%-3K
Financing cash flow
Cash flow from continuing financing activities	212.22%35.6M	826.81%34.35M	-94.00%21K	-91.74%1.19M	-96.86%44K	-80.69%11.4M	-52,411.11%-4.73M	-88.95%350K	-64.90%14.38M	-90.61%1.4M
Net issuance payments of debt	--0	----	----	----	----	-131.59%-4.74M	----	----	----	----
Net common stock issuance	301.78%35.6M	286,141.67%34.35M	-94.02%21K	-83.26%1.19M	-96.86%44K	-73.49%8.86M	124.49%12K	-89.87%351K	-76.36%7.1M	--1.4M
Proceeds from stock option exercised by employees	--0	----	----	----	----	6,641.67%7.28M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	212.22%35.6M	826.81%34.35M	-94.00%21K	-91.74%1.19M	-96.86%44K	-80.69%11.4M	-52,411.11%-4.73M	-88.95%350K	-64.90%14.38M	-90.61%1.4M
Net cash flow
Beginning cash position	-39.03%31.6M	-73.34%11.51M	-65.43%17.97M	-49.50%23.29M	-39.03%31.6M	175.39%51.83M	-27.78%43.16M	-24.06%51.99M	68.08%46.12M	175.39%51.83M
Current changes in cash	139.91%8.08M	343.64%28.17M	26.77%-6.47M	-190.69%-5.32M	-45.52%-8.31M	-161.29%-20.23M	-44.13%-11.56M	-2.58%-8.83M	-85.70%5.87M	-166.21%-5.71M
End cash Position	25.56%39.67M	25.56%39.67M	-73.34%11.51M	-65.43%17.97M	-49.50%23.29M	-39.03%31.6M	-39.03%31.6M	-27.78%43.16M	-24.06%51.99M	68.08%46.12M
Free cash flow	12.98%-27.53M	9.55%-6.18M	29.34%-6.49M	23.50%-6.51M	-17.43%-8.35M	-21.24%-31.63M	14.69%-6.84M	22.29%-9.18M	-15,028.07%-8.51M	-12.43%-7.11M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall